The national insurers’ financial performance in Q3 2025: MLRs continue to worsen even as overall performance is relatively strong
At a glance
Read on to get our full commentary, or use the links below to jump to a specific area of interest:
Over the past few weeks, all five national, publicly traded health plans have hosted their third set of earnings calls for the year, sharing their performance from Q3 and their outlook for the remainder of 2025. We make it a point to stay on top of these players’ performance to monitor the health insurance industry’s overall financial position and to see what the data tell us about ongoing demographic shifts, the margin outlook for providers, the real-world/cost implications of innovations from the drug pipeline, and the state of the regulatory environment. Investor calls tend to tell the real story about an organization’s intentions—which often diverges from media interviews or carefully crafted press releases. You can find our analysis of the “Big Five” national insurers’ financial performance in Q1 linked here and Q2 linked here.
In today’s post, we’ll summarize the trends we’re seeing across Q3 performance, dive into the details of the “Big Five” national insurers’ financial performance, and outline what we’re watching moving forward.
High-level trends across the national insurers’ financial performance in Q3 2025
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
The Great Utilization Shift
For-profit health systems’ financial performance in 2025—and what to expect in 2026
The national insurers’ financial performance in Q4 2025: How the Big Five insurers weathered 2025—and what to expect in 2026